Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: blob (6), smudge (1), smear (12), blot (1)

Raised BMI in pregnancy - patient information

Description: Patient information factsheet Raised body mass index (BMI) in pregnancy, labour and birth Having a raised body mass index increases the
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Raised-BMI-in-pregnancy.pdf

DVd_Twice weekly_Daratumumab-Bortezomib-Dexamethasone_Cycles 1 to 8

Description: Chemotherapy Protocol Myeloma DVd (twice weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 1 to 8) Regimen • Myeloma – Bortezomib (twice weekly)-Daratumumab-Dexamethasone Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Twice-weekly-Daratumumab-Bortezomib-Dexamethasone-Cycles-1-to-8.pdf

DVd Weekly Daratumumab-Bortezomib-Dexamethasone Cycles 1 to 8

Description: Chemotherapy Protocol Myeloma DVd (Weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 1 to 8) Regimen • Myeloma – Bortezomib (weekly)-Daratumumab-Dexamethasone Indication • Daratumumab in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Weekly-Daratumumab-Bortezomib-Dexamethasone-Cycles-1-to-8.pdf

jointtrainrev_08

Description: <!-- Hide from scriptless browsers snapAddEvent(window, 'load', snapInit); // Global settings var pageNumber=0; var lastPageNumber=0; var pBars=12; var hasSubm
Url: /suhtapps/Surveys/jointtrainrev_08.htm

pctdischarge_anti_coag08

Description: <!-- Hide from scriptless browsers snapAddEvent(window, 'load', snapInit); // Global settings var pageNumber=0; var lastPageNumber=0; var pBars=12; var hasSubm
Url: /suhtapps/Surveys/pctdischarge_anti_coag08.htm

pctdischarge08

Description: <!-- Hide from scriptless browsers snapAddEvent(window, 'load', snapInit); // Global settings var pageNumber=0; var lastPageNumber=0; var pBars=12; var hasSubm
Url: /suhtapps/Surveys/pctdischarge08.htm

portsmouth_hospitals_health_survey_08

Description: <!-- Hide from scriptless browsers snapAddEvent(window, 'load', snapInit); // Global settings var pageNumber=0; var lastPageNumber=0; var pBars=12; var hasSubm
Url: /suhtapps/Surveys/portsmouth_hospitals_health_survey_08.htm

Isatuximab VRD weekly

Description: Chemotherapy Protocol Myeloma Isa-VRD weekly Isatuximab-Lenalidomide-Bortezomib-Dexamethasone (20) Regimen Myeloma – Isa-VRD weekly Isatuximab-Lenalidomide-Bortezomib-Dexamethasone (20
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Isatuximab-VRD-weekly-Ver1.pdf

DVd-T SC Bortezomib-Daratumumab-Dexamethasone-Thalidomide v1

Description: Details of the Chemotherapy Protocol for Myeloma.
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-T-SC-Bortezomib-Daratumumab-Dexamethasone-Thalidomide.pdf

DVdSC (weekly cycles1-8) Bortezomib-Daratumumab-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly cycles 1-8) Bortezomib-Daratumumab-Dexamethasone Regimen • Myeloma – DVd SC (weekly cycles 1-8) bortezomib
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles1-8-Bortezomib-Daratumumab-Dexamethasone-Ver1.pdf

81 to 90 of 90

Previous … 5 6 7 8 9 Next